Tag: Androgel
AbbVie Wins Appeal Over Perrigo’s AndroGel Antitrust Lawsuit
AbbVie Inc. escaped antitrust litigation over its blockbuster testosterone booster AndroGel 1%, when a federal appeals court in Philadelphia ruled Thursday that rival Perrigo Co. waived its...
Pharmaceutical Patents, Settlements, Reverse Payments, and Exclusion: Update
John Bigelow, Jul 27, 2012
In the June issue of this Chronicle my fellow contributors and I described a trend in appellate court decisions involving...
Pharmaceutical Patents, Settlements, Reverse Payments, and Exclusion
John Bigelow, Jun 27, 2012
Cases involving pharmaceuticals settlements to patent litigation with so called "reverse payments" or, as the FTC now prefers to call...
Eleventh Circuit Rejects the Strength of a Patent as a Criterion...
Jodi Lucena-Pichardo, William Rooney, Jun 27, 2012
The Eleventh Circuit's recent decision in Federal Trade Commission v. Watson Pharmaceuticals, Inc. (the "AndroGel" decision) addresses the latest...
